ROSA Total Knee Post Market Study EMEA
← catalyst calendarSponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Non randomized · None · Treatment
Enrollment
252actual
Sites
6
Countries
Belgium, Germany, Israel +2
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2020-12-15 | actual | When the study began enrolling |
| Primary completion | 2025-08-22 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-08-22 | actual | The whole study's end, after follow-up |
| First posted | 2020-04-08 | actual | When this record first appeared on the registry |
| Results posted | 2026-01-21 | actual | When the sponsor posted results to the registry |
| Record updated | 2026-05-12 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Knee Pain
- Chronic Osteoarthritis
- Avascular Necrosis of the Femoral Condyle
- Moderate Varus, Valgus or Flexion Deformities
- Rheumatoid Arthritis
Interventions
- Procedure: Device: Persona Total Knee
- Procedure: Device: NexGen Total Knee
- Procedure: Device: Vanguard Total Knee
Primary outcome
what the primary-completion date above is the date OFAlignment Accuracy
measured Pre-operative, 3 months
Posted documents
hosted by the registry — we link, never re-serveStudy Protocol and Statistical Analysis Planposted 2020-02-04 · 170 KB · Prot_SAP_000.pdf
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed